Maize Analytics' CEO Discusses Often Forgotten Risk to Patient Data

Wednesday, June 13, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

Researcher access to patient data presents monitoring challenges for Compliance Officers

NASHVILLE, Tenn., June 13, 2018 /PRNewswire/ -- Academic medical centers and health systems with large research groups

present unique challenges for EMR access monitoring programs, according to a recent talk by Dr. Daniel Fabbri, Founder and CEO of Maize Analytics. Dr. Fabbri, also an Assistant Professor of Bioinformatics and Computer Sciences at Vanderbilt University, spoke on balancing the need to provide electronic medical record (EMR) access to researchers, while also ensuring patient privacy. The talk was part of the Health Care Compliance Association's recent Research Compliance Conference held in Austin, Texas.

In his presentation, "Strategies to Effectively Monitor Researchers' Access to the EMR," Dr. Fabbri dove into the risk posed by researchers with access to electronic health records, and what makes monitoring researchers' accesses so difficult. Approaches used to monitor clinician accesses are not directly transferable to detect researcher misuse, he says.

"Over the past several years we've seen the threat of breaches from insiders growing," says Dr. Fabbri. "Researchers are a special class of insider whose work can involve seemingly erratic access patterns, making them difficult to monitor. As a result, standard methods, like rules-based auditing and anomaly detection, are not sufficient for monitoring researchers, creating a significant risk to patient data."

The talk spurred a discussion about procedures, processes and tools covered entities can employ to ensure researchers' EMR accesses comply with HIPAA and institutional policies. According to Dr. Fabbri, this starts with researchers' applications to the Institutional Review Board (IRB).

"Including structured diagnosis and procedure codes in the IRB application provides a guide for compliance officers to understand what constitutes appropriate access for each researcher," he says.

Covered entities can integrate IRB submission data within their access monitoring tools to more effectively detect inappropriate behavior, continues Dr. Fabbri. "These research-aware monitoring tools can identify when a project goes beyond the listed research scope and alert the compliance department."

The presentation—attended by researchers, compliance teams, and HIPAA officers alike—concluded with Dr. Fabbri providing monitoring recommendations and guidance so that healthcare organizations can monitor the various types of access to patient data.

Learn More About Maize Analytics Here

Cision View original content:http://www.prnewswire.com/news-releases/maize-analytics-ceo-discusses-often-forgotten-risk-to-patient-data-300665818.html

SOURCE Maize Analytics



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store